由于监管不力和执法延迟,印度面临中国聚氯乙烯树脂受污染的健康风险。 India faces health risks from contaminated Chinese PVC resin due to weak regulations and delayed enforcement.

一份新报告警告印度公众健康面临风险, 因为进口的中国聚氯乙烯树脂(PVC树脂)的含量是已知致癌物(RVCM)安全水平的五倍。 A new report warns India’s public health is at risk due to imported Chinese PVC resin containing up to five times the safe level of RVCM, a known carcinogen. 这项研究于2025年11月13日在德里国际信息技术研究所发布, 发现印度缺乏关于该污染物的具有约束力的国家标准, 与美国、欧盟和泰国不同。 The study, released at IIT Delhi on November 13, 2025, finds India lacks binding national standards for this contaminant, unlike the U.S., EU, and Thailand. 尽管2024年8月发布了一项拟议的质量控制令,但执行仍被推迟到2025年12月。 Despite a proposed Quality Control Order issued in August 2024, enforcement is delayed until December 2025. 聚氯乙烯对于水、保健和建筑至关重要,超过39个外国供应商——出口多于国内需求——已经持有国际清算银行证书。 PVC is critical for water, healthcare, and construction, and over 39 foreign suppliers—exporting more than domestic demand—already hold BIS certification. 专家们敦促迅速实施,以确保安全并支持国内工业。 Experts urge swift implementation to ensure safety and support domestic industry.